Improvement effects of glycyrrhizin on Helicobacter pylori-associated gastritis in rats and its mechanism
- VernacularTitle:甘草甜素对大鼠幽门螺杆菌相关性胃炎的改善作用及机制
- Author:
Yuhua LIU
1
;
Lian LIU
2
;
Jiuchong WANG
3
;
Dan HUANG
4
;
Sufang ZHOU
4
;
Huanzhi XIAO
4
;
Zhenxiang AN
4
Author Information
1. The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine，Guiyang 550001，China
2. Teaching and Research Section of Clinical Microbiology and Immunology，Guizhou Medical University，Guiyang 550001，China
3. Dept. of Infectious Diseases，Guang’anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
4. Dept. of Gastroenterology，the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine，Guiyang 550001，China
- Publication Type:Journal Article
- Keywords:
glycyrrhizin;
high mobility group box 1 protein;
nuclear transcription factor-κB;
Helicobacter pylori-associated
- From:
China Pharmacy
2024;35(2):166-171
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the improvement effects of glycyrrhizin （GL） on Helicobacter pylori （HP）-associated gastritis in rats and its mechanism. METHODS HP-associated gastritis rat model was induced by inoculating with 1×109 cfu/mL HP. The model rats were randomly divided into model group， positive control group （HP standard quadruple group）， GL low-dose， medium-dose and high-dose groups （5， 20， 50 mg/kg）， with 12 rats in each group. Another 12 healthy rats were selected as normal control group. Except the normal control group and model group were given constant volume of normal saline intragastrically， the other groups were given corresponding drugs intragastrically， once a day， for 30 consecutive days. After administration， rats received 13C urea breath test， and delta-over-baseline （DOB） was recorded； the pathological and cellular morphological changes of gastric mucosa in rats were observed， and pathological scoring was performed； the levels of interleukin-8 （IL-8）， IL-1β， tumor necrosis factor-α （TNF-α）， reactive oxygen species （ROS） and malondialdehyde （MDA） were detected in gastric mucosa of rats； mRNA expressions of high mobility group box-1 protein （HMGB1） and nuclear factor-κ-B （NF-κB）， relative expressions of nitric oxide synthases （iNOS） and HMGB1， the phosphorylation level of NF- κBp65 were also detected in rats. RESULTS Compared with normal control group， the DOB value， histopathological score of gastric mucosa， the levels of IL-8， IL-1β， TNF-α， ROS and MDA， relative expressions of HMGB1 and NF- κB mRNA， relative expressions of iNOS and HMGB1 protein and the phosphorylation level of NF-κB p65 were all increased significantly in model group （P＜0.05）； the epithelial cells of gastric mucosa in rats were incomplete in structure and decreased in the number， with an increase in cell fragments and vacuoles， and significant cell pyknosis. Compared with model group， the changes of the above indexes in GL groups and positive control group were significantly reversed （P＜0.05）； the changes in the above indicators in the GL high-dose group were more significant than GL low-dose and medium-dose groups （P＜0.05）； the pathological changes of gastric mucosal cells in rats had all improved. CONCLUSIONS GL may inhibit inflammation and oxidative stress by inhibiting the activation of HMGB1/NF-κB pathway， thus relieving HP-induced gastric mucosal injury.
